Stefan Sarafianos, University of Missouri School of Medicine (IMAGE)

University of Missouri School of Medicine

Stefan Sarafianos, University of Missouri School of Medicine

Caption

With a new $3.4 million grant from the National Institutes of Health, scientist Stefan Sarafianos, Ph.D., MU Chancellor's Chair for Excellence in Molecular Virology, is developing new compounds that target an enzyme in HIV that has escaped the reach of existing drugs.

Credit

University of Missouri School of Medicine

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.